Spine biologics market to grow at CAGR of 4.09% through 2022

Biologics

The global spine biologics market is expected to grow at a compound annual growth rate of 4.09 percent from 2018 to 2022, according to a 360 Market Updates report.

Key vendors in the spine biologics market include:

1. Alphatec Spine

2. Globus Medical

3. Medtronic

4. NuVasive

5. AlloSource

6. Amendia

7. ChoiceSpine

8. DePuy Synthes

9. Exactech

10. Harvest Technologies

More articles on biologics:

3 things to know about Lattice Biologics

8 key surgeon Q&As on biologics in orthopedics & spine

International Stem Cell Corp. to launch joint supplement for osteoarthritis pain in Q3 2018

Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Webinars

Featured Podcast

Featured Whitepapers